{"id":8692,"date":"2020-03-18T08:00:16","date_gmt":"2020-03-18T05:00:16","guid":{"rendered":"https:\/\/www.anm.ro\/en\/?p=8692"},"modified":"2020-03-25T16:29:50","modified_gmt":"2020-03-25T13:29:50","slug":"important-notification-18-03-2020","status":"publish","type":"post","link":"https:\/\/www.anm.ro\/en\/important-notification-18-03-2020\/","title":{"rendered":"Important notification"},"content":{"rendered":"<p><strong>18.03.2020<\/strong><br \/>\n<span style=\"color: #333399;\"><strong>To the attention of interested persons<\/strong><\/span><br \/>\nSupplementing NAMMDR notification of 12.03.2020 on submission of documents in the current epidemiological context requiring limitation to the utmost extent possible of Registry Service work, please be advised on specific details aimed to streamline admission of documents addressed to the Clinical Trials Directorate (CTD).<br \/>\nTherefore, please note:<br \/>\nDocuments to CTD attention may be admitted as follows:<br \/>\n1. electronically, as follows:<br \/>\n\u2013 letters of intent, payment forms and various notifications are to be sent to <a href=\"mailto:registratura@anm.ro\">registratura@anm.ro<\/a>;<br \/>\n\u2013 documentation related to important amendments or clinical trial are to be sent directly to the CTD, using the Upload platform, to <a href=\"mailto:aurora.nicula@anm.ro\">aurora.nicula@anm.ro<\/a>, with specification of the registration number provided in the confirmation of payment;<br \/>\n\u2013 documentation related to authorisation of healthcare facilities as clinical trial sites are to be submitted directly to the CTD, using the Upload platform to <a href=\"mailto:aida.goran@anm.ro\">aida.goran@anm.ro<\/a>, with specification of the full name of the healthcare facility and the valid contact email address;<br \/>\n\u2013 documentation accompanying notifications is to be submitted directly to the CTD, using the Upload platform, to <a href=\"mailto:aurora.nicula@anm.ro\">aurora.nicula@anm.ro<\/a>, with the specification Notification + brief summary, e.g. DSUR, non-important amendment etc.<br \/>\n2. by regular mail or courier (if the above is not feasible)<br \/>\nPlease note that submission using CESP or PCUe is not applicable for the Clinical Trials Directorate.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>18.03.2020 To the attention of interested persons Supplementing NAMMDR notification of 12.03.2020 on submission of documents in the current epidemiological [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[],"class_list":["post-8692","post","type-post","status-publish","format-standard","hentry","category-covid-19-studii-clinice"],"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/posts\/8692","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/comments?post=8692"}],"version-history":[{"count":1,"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/posts\/8692\/revisions"}],"predecessor-version":[{"id":8693,"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/posts\/8692\/revisions\/8693"}],"wp:attachment":[{"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/media?parent=8692"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/categories?post=8692"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.anm.ro\/en\/wp-json\/wp\/v2\/tags?post=8692"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}